SCHEMBL19081695

SCHEMBL19081695

c1ccc2c(c1)ccc1c2oc2ccc3oc4ccc(-c5c6ccccc6c(-c6ccc7oc8ccccc8c7c6)c6ccccc56)cc4c3c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 10/20 0.40
CYP1B1 Q16678 10/20 0.40
KDM4E B2RXH2 3/20 0.40
MAPT P10636 3/20 0.40
HPGD P15428 3/20 0.40
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
CYP1A2 P05177 9/20 0.39
ABCB1 P08183 3/20 0.39
ABCC1 P33527 3/20 0.39
ABCG2 Q9UNQ0 3/20 0.39
PRKDC P78527 2/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17122576 0.93 CYP1A1 (0.43) CYP1A1CYP1B1KDM4EMAPTHPGD
SCHEMBL19081462 0.92 CYP1A1 (0.49) CYP1A1CYP1B1KDM4EMAPTHPGD
SCHEMBL19081426 0.92 CYP1A1 (0.45) CYP1A1CYP1B1KDM4EMAPTHPGD
SCHEMBL19081696 0.92 TDP1 (0.42) CYP1A1CYP1B1KDM4EMAPTHPGD
SCHEMBL19081692 0.91 CYP1A1 (0.38) CYP1A1CYP1B1KDM4EMAPTHPGD
SCHEMBL27264822 0.91 TDP1 (0.41) CYP1A1CYP1B1KDM4EMAPTHPGD
SCHEMBL16067693 0.90 CYP1A1 (0.41) CYP1A1CYP1B1KDM4EMAPTHPGD
SCHEMBL17945178 0.90 CYP1A1 (0.41) CYP1A1CYP1B1KDM4EMAPTHPGD
SCHEMBL22062827 0.90 CYP1A1 (0.41) CYP1A1CYP1B1KDM4EMAPTHPGD
SCHEMBL21687085 0.90 ALOX5 (0.40) CYP1A1CYP1B1KDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11367838-B2 Anthracene derivative and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2022-06-21 US disclosed
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885KDM4E 3720/4885
US-11367838-B2 Anthracene derivative and organic light-emitting device comprising same CCNL2, CRY1, CYP2S1 CYP1A1 5/4885CYP1B1 55/4885KDM4E 3061/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885KDM4E 3720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.